| Today's News and Trends | In an op-ed published by The Hill, a policy expert calls for a paradigm shift in which the U.S. addresses the shortage of doctors with supportive policy that alleviates the hefty price tag of medical school. In an op-ed published by The Hill, a policy expert calls for a paradigm shift in which the U.S. addresses the shortage of doctors with supportive policy that alleviates the hefty price tag of medical school. | | |
| Since 2024, the VA-OIG has been using the popular AI chatbot to pull necessary records and data to conduct its regulatory audits, a media report reveals. Since 2024, the VA-OIG has been using the popular AI chatbot to pull necessary records and data to conduct its regulatory audits, a media report reveals. | | |
| In total, Helen Boerman, an optometric physician, admitted to sending $11 million in false claims to various government healthcare programs. She will spend the next three-and-a-half years in prison. In total, Helen Boerman, an optometric physician, admitted to sending $11 million in false claims to various government healthcare programs. She will spend the next three-and-a-half years in prison. | | |
| | The deal, which sources told reporters could be finalized as early as next week, would mean GE HealthCare would become the sole owner of the private-equity backed radiopharmaceutical developer. The deal, which sources told reporters could be finalized as early as next week, would mean GE HealthCare would become the sole owner of the private-equity backed radiopharmaceutical developer. | | |
| The details come from the New York Times, whose reporters found that Sen. Roger Marshall, MD, (R-KS) sued patients for as little as $101 during his two decades working as an OB-GYN. The details come from the New York Times, whose reporters found that Sen. Roger Marshall, MD, (R-KS) sued patients for as little as $101 during his two decades working as an OB-GYN. | | |
| Oleksii Oleksiyovych Lytvynenko, 44, was arrested in Ireland in 2023. As part of the cybercrime group linked to the deployment of Conti, Lytvynenko was found to have possessed data from 12 victims. He pleaded guilty to conspiracy to commit wire fraud. Oleksii Oleksiyovych Lytvynenko, 44, was arrested in Ireland in 2023. As part of the cybercrime group linked to the deployment of Conti, Lytvynenko was found to have possessed data from 12 victims. He pleaded guilty to conspiracy to commit wire fraud. | | |
| | The Texas-based company is buying Precision Medicine Group, a Maryland-based company that supports cancer drug development with a variety of resources, including data and labs. The Texas-based company is buying Precision Medicine Group, a Maryland-based company that supports cancer drug development with a variety of resources, including data and labs. | | |
| Many nurses have spent untold hours at the bedsides of frail and fading inpatients who, despite having blood relatives in the vicinity, rarely receive visitors. In these scenarios, it’s only human for a healthcare worker to feel some measure of resentment toward the absentee family. Many nurses have spent untold hours at the bedsides of frail and fading inpatients who, despite having blood relatives in the vicinity, rarely receive visitors. In these scenarios, it’s only human for a healthcare worker to feel some measure of resentment toward the absentee family. | | |
| | Clinicians have believed for years that menopause was responsible for a dramatic shift in pulse pressure that occurs in women as they age. According to a large new study, however, that change appears to occur years before menopause even begins. Clinicians have believed for years that menopause was responsible for a dramatic shift in pulse pressure that occurs in women as they age. According to a large new study, however, that change appears to occur years before menopause even begins. | | |
| Pixclara is a radioactive diagnostic drug paired with PET imaging, used to help doctors distinguish between returning brain cancer or harmless changes caused by previous treatment. Pixclara is a radioactive diagnostic drug paired with PET imaging, used to help doctors distinguish between returning brain cancer or harmless changes caused by previous treatment. | | |
| |
|
| ![]() | |
|